During the past decade, Centrum Alergologii Teresa Hofman conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Alergologii Teresa Hofman" #1 sponsor was "HAL Allergy" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Artu Biologicals" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Alergologii Teresa Hofman" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Alergologii Teresa Hofman" are "Asthma" (4 trials), "Allergic Rhinoconjunctivitis" (3 trials), "Allergic Rhinitis" (2 trials), "Atopic Dermatitis" (2 trials) and "Birch Pollen Induced Rhinitis/Rhinoconjunctivitis" (1 trials). Many other conditions were trialed in "Centrum Alergologii Teresa Hofman" in a lesser frequency.

Most popular intervention types in "Centrum Alergologii Teresa Hofman" are "Drug" (8 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Lebrikizumab" (4 trials), "SUBLIVAC FIX Birch" (2 trials), "Astegolimab" (1 trials) and "MTPS9579A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Alergologii Teresa Hofman" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Alergologii Teresa Hofman". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centrum Alergologii Teresa Hofman, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Alergologii Teresa Hofman, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".